Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Large interest in the newly launched clinical trial for 2cureX’s IndiTreat™ test

2cureX AB (“2cureX”) and its clinical partners have launched a clinical trial where IndiTreat ™ supports the oncologist in providing the most effective treatment for patients with stage IV colorectal cancer. IndiTreat™ generates micro-tumors from the patient’s cancer tissue and challenges these micro-tumors with a large panel of standard and off-label treatments. The treatment that stops the growth and kills the micro-tumors from the individual patient is then offered by the oncologist to the patient.The clinical trial was launched in Denmark end of October and will in 2018 be extended to

Verizon awards 5G contract to Ericsson

· Companies to deploy commercial 5G network in select US markets in second half of 2018 · Ericsson to provide 5G Core network, 5G Radio Access Network (RAN), transport and associated services · First pre-standard deployment paves the way for accelerated 5G commercialization of 3GPP-standards based solutionsVerizon has selected Ericsson (NASDAQ: ERIC) to provide networking equipment for their commercial 5G launch. Verizon will deploy the pre-standard 5G commercial radio network and the 5G Core network in select markets in second half of 2018. The companies are demonstrating

Aker ASA: Kristian Røkke appointed as Chief Investment Officer

Aker ASA (“Aker”) has appointed Kristian Røkke as its Chief Investment Officer effective 1 January 2018. Mr. Røkke is currently the Chief Executive Officer of Akastor ASA (“Akastor”), a publicly listed oil service investment company, and will be succeeded by Karl Erik Kjelstad from 1 January 2018. In connection with the transition, Mr. Røkke will resign from Aker’s Board of Directors, but continue as a Board member of TRG Holding AS, Aker’s principal shareholder.Aker will propose to the nomination committee of Akastor that Kristian Røkke assume the position as Chairman of the Board of

Akastor ASA: Karl Erik Kjelstad appointed new CEO; Kristian Røkke proposed nominated as Chairman

Akastor ASA announced that its Board of Directors has appointed Karl Erik Kjelstad as its Chief Executive Officer effective from 1 January 2018. Mr. Kjelstad will succeed Kristian Røkke who will assume the position as Chief Investment Officer of Aker ASA on 1 January 2018. Aker ASA will propose to the nomination committee of Akastor ASA that Kristian Røkke is appointed as Chairman of the Board of Akastor ASA at the next Annual General Meeting. "It has been a pleasure to lead Akastor and I am proud of what the team has accomplished. The company has focused its portfolio, strengthened its

Share capital registered

Oslo, 11 December 2017 - Reference is made to the announcement on 23 November 2017 by MPC Container Ships AS (the "Company") regarding the successful completion of the private placement of 30,250,000 new shares (the "Private Placement") and the Company's extraordinary general meeting held on 4 December 2017 which approved the share capital increase relating to the issuance of the new shares in the Private Placement. NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE

Vessel Acquisitions

Oslo, 11 December 2017 - MPC Container Ships AS (the "Company") is pleased to announce that it has entered into agreements to acquire “Vilana” (tbn “AS Cleopatra”), “Cap Pasado” (tbn “AS Christiania”) and “Cap Blanche” (tbn “AS Carlotta”). Oslo, 11 December 2017 - MPC Container Ships AS (the "Company") is pleased to announce that it has entered into agreements to acquire “Vilana” (tbn “AS Cleopatra”), “Cap Pasado” (tbn “AS Christiania”) and “Cap Blanche” (tbn “AS Carlotta”), three 2,742 TEU vessels built in 2006 at Aker MTW Werft, Germany. The total purchase price for the three vessels

Searching for the best hiking and cycling photos: submit your images of the E1 European Long-Distance Path and R1 Euroroute now

Competition for fans of photography and professionals: from 1st December, hikers and cyclists can upload their most beautiful photos of the E1 or R1 routes via www.e1r1-photoaward.eu. There are prizes with a total value of around €50,000 to be won.Earlier this year, WALK, the competence centre for hiking in Detmold, created the E1|R1 Photo Award. With the launch of submissions, the first international photo competition for the E1 European Long-Distance Path and the Euroroute R1 is now entering the decisive rounds. From now, ambitious amateur photographers and professionals can

Ossur Hf : Transactions in relation to share buyback program

Announcement from Össur hf. No. 86/2017Reykjavík, 11 December 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017.  The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 31 July 2018. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.1% of the current share capital. The total consideration for

#17-42 Delisting of Instrument issued by Commerzbank AG

After the end of today’s trading, 1 Instrument issued by Commerzbank AG will be delisted from ETP Norway.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 10 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange

Publication of a Prospectus

Regulatory Announcement Royal Bank of CanadaDecember 11, 2017 Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. The following prospectus has been approved by the UK Listing Authority and is available for viewing: 4th Supplementary Notes Base Prospectus dated December 11, 2017 relating to the Programme for the Issuance of Securities of Royal Bank of Canada. The 4th Supplementary Notes Base Prospectus, together with the documents incorporated by reference therein, have been submitted to the

New data show extended prophylactic dosing with Alprolix® provides safe and effective protection in people with severe haemophilia B

Post-hoc longitudinal analysis from B-LONG and B-YOND studies shows patients who progressed to individualised prophylactic dosing intervals of 14 days or longer maintained low annualised bleeding rates.Swedish Orphan Biovitrum AB (publ)  (Sobi™)(STO:SOBI) and Bioverativ Inc.  (NASDAQ: BIVVV) today announce the results of a new post-hoc longitudinal analysis demonstrating that individualised dosing with extended half-life therapy, Alprolix® (eftrenonacog alfa), every 14 or more days may be a potential option for people with severe

Resolutions at the extraordinary general meeting of Nuevolution AB (publ)

At the extraordinary general meeting of Nuevolution AB (publ) on 11 December 2017, the following resolutions were resolved.                                     Number of board members It was resolved that the number of board members, as appointed by the general meeting, should be six with no deputies. Remuneration to the board members It was resolved that remuneration to the board of directors on a full year basis shall be paid in a total amount of SEK 1,520,000, which entails an increase on a full year basis of SEK 200,000 for the additional member of the board of directors. It

Revenio Group Corporation: Revenio acquires minority interest in Oscare Medical Oy

Revenio Group Corporation, Stock Exchange Release December 11, 2017 at 17:00 EET                                                                               REVENIO ACQUIRES MINORITY INTEREST IN OSCARE MEDICAL OY  Revenio Group Corporation ("Revenio", "the company") has signed an agreement to purchase the minority interest in Oscare Medical Oy, a stake of 46.5% in the company. Following the transaction, Revenio Group Corporation will own 100% of Oscare Medical Oy. Prior to the arrangement, Oscare Medical Oy was a Group company that was 53.5% owned by Revenio Group Corporation. As

#17-41 Listing of Knock out warrants issued by Vontobel Financial Products GmbH

As from December 12, 2017, 8 Knock out warrants issued by Vontobel Financial Products GmbH will be listed on ETP Finland and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Finland Oy.Issuer: Vontobel Financial Products GmbH Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from December 12, 2017 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: DAX 30 Index Nokia Oyj Current values of strike and barrier can be found at: [ NGM

UPDATE ON PROPOSED INVESTMENT INTO EMAS OFFSHORE LIMITED AND RESTRUCTURING

1.         Introduction 1.1       The Board of Directors (the “Board”) of EMAS Offshore Limited (the “Company” and together with its subsidiaries, the “Group”) refers to the announcements made on 31 August 2017, 4 September 2017 and 26 September 2017 (“Previous Announcements”).  Unless otherwise defined, terms used in the Previous Announcements shall have the same meanings when used herein. 2.         Update on Investment by the Potential Investors 2.1        It was announced in the Previous Announcement that, inter alia, the Term Sheet may be terminated, and the Restructuring

Transfer of Etteplan Oyj’s own shares

ETTEPLAN OYJ, Stock exchange release, December 11, 2017, at 16.30 Transfer of Etteplan Oyj’s own shares Etteplan Oyj has today December 11, 2017 transferred a total of 35,000 own shares to Vataple Ltd. The transfer relates to a transaction, published in August 2017, in which Etteplan acquired full ownership of Etteplan Vataple Technology Centre, Ltd, which previously operated as a joint venture. The acquisition has now been registered in China. The shares were purchased to Etteplan Oyj based on the Board of Directors’ decision on June 21, 2016. For the transfer, Etteplan’s Board of

The Board of Directors of Valmet Oyj decided on a new share-based incentive plan for key employees

Valmet Oyj's stock exchange release on December 11, 2017 at 4:15 p.m. EET The Board of Directors of Valmet Oyj has decided on a new long-term share-based incentive plan for Valmet's key employees. The aim of the plan is to combine the objectives of the shareholders and the key employees in order to increase the value of the Company in the long run, to commit the key employees to the Company, and to offer them a competitive reward plan based on holding the Company's shares. The plan includes three discretionary periods, which are the calendar years 2018, 2019 and 2020. Valmet's Board

FundedByMe reaches maximum goal for own crowdfunding campaign and raises 20 million SEK from 867 investors.

FundedByMe launched its own crowdfunding campaign on the 10th of November 2017. Only after 24 hours the campaign reached the target of 9 millions SEK. Step by step the campaign was strategically released via offline and online marketing activities and closed 500% over-funded on the 3rd of December 2017. The 20 million SEK secured investment by 867 participating investors is equivalent to 8,02% of FundedByMe’s total shareholding.     FundedByMe has prior announced plans for an IPO during 2018 and has showed strong growth for 2017. Furthermore the company has passed the 100.000 mark for

Vestas - Transactions in connection with share buy-back programme during the period 4 – 8 December 2017

On 17 August 2017, Vestas initiated a share buy-back programme, ref. Company announcement No. 30/2017 . The programme is implemented in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (the "Safe Harbour” rules). The purpose of the programme is to adjust Vestas’ capital structure and to meet the obligations arising from share based incentive programmes to employees of Vestas.  Under the programme, Vestas will buy back shares for an amount up to

Report from the Extraordinary General Meeting of Clavister Holding AB held on December 11, 2017

Clavister Holding AB held an Extraordinary General Meeting on Monday, December 11, 2017. The main resolutions passed at the meeting were as follows: More detailed information about the contents of the resolutions may be obtained from the complete notice of the EGM and the complete proposals. The notice and the proposals are available on the Company’s website, www.clavister.com. Election of a new board of director, number of directors and directors’ fees Since the former chair of the board of directors Björn Norrbom and the board director Ilkka Hiidenheimo have resigned from their

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock, Inc ownership in Valmet exceeds 5 percent

Valmet Oyj's stock exchange release on December 11, 2017 at 4:00 p.m. EET Valmet Oyj has on December 11, 2017 received a notification referred to in Securities Market Act from BlackRock, Inc, stating that the company's ownership and share of votes in Valmet Oyj has exceeded the threshold of 5 percent. As a result of share transactions on December 8, 2017, the holding of BlackRock, Inc increased to 7,494,048 shares, representing an ownership of 5.00 percent of Valmet Oyj's total number of shares and share of votes. Valmet Oyj has one series of shares in which each share carries one

Inhalation Sciences Newsletter - The latest medical and business news from Inhalation Sciences

December 11, 2017INHALABLE VACCINES & THE FIGHT AGAINST TB: DDL2017 HIGHLIGHTS It’s the largest, most important event in Europe’s pulmonary drug delivery calendar—this year there were more visitors, and research posters, than ever at the Drug Delivery to the Lungs (DDL) Conference, Edinburgh, December 6-8. What were the highlights? READ MORE: http://www.inhalation.se/en/inhalable-vaccines-the-fight-against-tb-ddl2017-highlights/  ISAB’S IN-VITRO TECHNOLOGY XPOSEALI® GRANTED PATENT IN CHINA  Inhalation Sciences’ patent application for XposeALI®, the company's unique, proprietary

#17-40 Listing of Knock out warrants issued by Commerzbank AG

As from December 12, 2017, 3 Knock out warrants issued by Commerzbank AG will be listed on ETP Denmark and will be included on the list for Knock-Outs. The instruments will be registered at VP SECURITIES A/S.Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from December 12, 2017 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: DAX 30 Index Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ] 

There are no items matching the current filter
There are no more items matching the current filter
Back to top